Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-09 · 1878 (5) · 188965
DOI: 10.1016/j.bbcan.2023.188965 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-09. Verfasst von Zhaoshi Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 21000…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 145 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Mitotic catastrophe is distinct from other cell death modes due to unique nuclear alterations characterized as multi and/or micronucleation. Mitotic catastrophe is a common and virtually unavoidable consequence during cancer therapy. However, a comprehensive understanding of mitotic catastrophe remains lacking. Herein, we summarize the anticancer drugs that induce mitotic catastrophe, including microtubule-targeting agents, spindle assembly checkpoint kinase inhibitors, DNA damage agents and DNA damage response inhibitors. Based on the relationships between mitotic catastrophe and other cell death modes, we thoroughly evaluated the roles played by mitotic catastrophe in cancer treatment as well as its advantages and disadvantages. Some strategies for overcoming its shortcomings while fully utilizing its advantages are summarized and proposed in this review. We also review how mitotic catastrophe regulates cancer immunotherapy. These summarized findings suggest that the induction of mitotic catastrophe can serve as a promising new therapeutic approach for overcoming apoptosis resistance and strengthening cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, China. Electronic address: zhaoshi_bai@njmu.edu.cn.
- Department of General Surgery, Rui Jin Hospital, Research Institute of Pancreatic Diseases, School of Medicine, Shanghai JiaoTong University, Shanghai 200025, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 211198, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 211198, China. Electronic address: lingman_ma@cpu.edu.cn.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Bai, Z., Zhou, Y., Peng, Y., Ye, X., & Ma, L. (2023). Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(5), 188965. https://doi.org/10.1016/j.bbcan.2023.188965
Vancouver
Bai Z, Zhou Y, Peng Y, Ye X, Ma L. Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(5):188965. doi:10.1016/j.bbcan.2023.188965
BibTeX
@article{Bai2023,
author = {Bai, Zhaoshi and Zhou, Yiran and Peng, Yaling and Ye, Xinyue and Ma, Lingman},
title = {Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {5},
pages = {188965},
doi = {10.1016/j.bbcan.2023.188965}
}
EUVIMED